Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- Check6 days agoChange DetectedThe page previously displayed a 403 Forbidden error, and now shows the full study record for the trial, including the overview, design, primary and secondary outcomes, eligibility criteria, and contacts/locations.SummaryDifference100%

- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a simple error screen and a Home link. Users cannot view the study details or related information on this page.SummaryDifference17%

- Check20 days agoChange DetectedA new revision tag was added (v3.7.0) and several related-topic entries were removed, indicating housekeeping updates to the page's metadata and topics.SummaryDifference0.1%

- Check34 days agoChange DetectedLung cancer is added as a MeSH term and a Related topics section now includes a MedlinePlus Genetics link. The revision label was updated to v3.6.6 from v3.6.5.SummaryDifference0.1%

- Check41 days agoChange DetectedThe addition '2015 ( U.S. NIH Grant/Contract )' was added to the Other Study ID Numbers to indicate NIH funding for the study.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating a new version tag. The older revision tag Revision: v3.6.4 and related topic items (Lung cancer, MedlinePlus Genetics) were removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.